Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New radiation therapy aims to shrink tough prostate cancers

NCT ID NCT05720130

First seen Feb 22, 2026 · Last updated May 13, 2026 · Updated 9 times

Summary

This study is for people with metastatic prostate cancer that has spread and is no longer controlled by hormone therapy. It tests a new drug called [212Pb]Pb-ADVC001, which delivers a precise dose of radiation directly to cancer cells. The goal is to find the safest and most effective dose and see if it can shrink tumors or slow the disease. About 100 participants will be enrolled.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PROSTATE CANCER are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Gold Coast University Hospital

    RECRUITING

    Southport, Queensland, 4215, Australia

    Contact

  • Princess Alexandra Hospital

    RECRUITING

    Brisbane, Queensland, 4102, Australia

    Contact

  • Royal Brisbane & Women's Hospital

    RECRUITING

    Brisbane, Queensland, 4029, Australia

    Contact

Conditions

Explore the condition pages connected to this study.